Congress
$1,001–$15,000
Traded Dec 24, 2024 · disclosed 3 days later
4 different filers disclosed GILD within 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 27, 2024 · Filed Nov 30, 2024
Gilead Sciences's Chief Medical Officer sold $477K of Gilead Sciences shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$477,381
Shares × reported transaction price
21 days after results of Nov 6, 2024, 76 days before results of Feb 11, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
A WARN layoff notice covering 72 workers was filed in Washington on November 13, 2024.
From the official state WARN list, 14 days before the trade. Shown for timing only; the two filings are separate
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
FDA approved Sunlenca on Nov 25, 2024, 2 days before this trade.
New use approved (efficacy supplement). Active ingredient: Lenacapavir Sodium. From openFDA. Dates only; no link between the two is implied
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.6% | +0.2% | −3.8% |
| 30 days | −2.3% | −3.1% | +0.9% |
| 90 days | +23.4% | −3.3% | +26.7% |
| 180 days | +15.8% | −1.8% | +17.6% |
| 365 days | +31.8% | +12.9% | +18.9% |
Past results only. Not a forecast.
Congress
Traded Dec 24, 2024 · disclosed 3 days later
4 different filers disclosed GILD within 90 days.
Andrew D Dickinson (Chief Financial Officer) sold ~$782K of Gilead Sciences
Planned saleAndrew D Dickinson (Chief Financial Officer) sold ~$11.2M of Gilead Sciences
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.